# clm_6963A9FE29D9

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 9,741,000,000 United States dollar  
valid_from: 2026-06-30  
valid_to: 2026-09-30  
published: 2026-08-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_8D15B1B2A78D  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 9,741,000,000 United States dollar", as of 2026-06-30 (until 2026-09-30). Claim clm_6963A9FE29D9, https://asof.is/claim/clm_6963A9FE29D9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2026, filed 2026-08-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/0000310158-26-000212-index.htm (primary, SEC EDGAR 10-Q Q2 FY2026, published 2026-08-07)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 12,592,000,000 United States dollar | valid 2026-03-31 to 2026-06-30 | conf 0.95 | superseded | superseded_by [clm_6963A9FE29D9](/claim/clm_6963A9FE29D9.md) | [clm_CC42DDED77FE](/claim/clm_CC42DDED77FE.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.